These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 90917)

  • 21. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM; Drayer DE
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphocytic and lymphocytoactive components in the etiopathogenic mechanisms of systemic lupus erythematosus. An analysis of the literature].
    Angela GC; Cavallo G; Fiorio C
    G Batteriol Virol Immunol; 1983; 76(1-6):25-42. PubMed ID: 6237017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-DNA antibody in procainamide-induced lupus erythematosus. Determinations using DNA fractionated by methylated albumin-Kieselguhr chromatography.
    Winfield JB; Davis JS
    Arthritis Rheum; 1974; 17(2):97-110. PubMed ID: 4544445
    [No Abstract]   [Full Text] [Related]  

  • 24. Procainamide-induced lupus syndrome in siblings.
    Novack MA; Paine R
    JAMA; 1975 Jun; 232(12):1269. PubMed ID: 48561
    [No Abstract]   [Full Text] [Related]  

  • 25. Procainamide-induced systemic lupus erythematosus.
    Sheldon PJ; Williams WR
    Ann Rheum Dis; 1970 May; 29(3):236-43. PubMed ID: 4194201
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunomodulatory effects of procainamide metabolites: their implications in drug-related lupus.
    Adams LE; Sanders CE; Budinsky RA; Donovan-Brand R; Roberts SM; Hess EV
    J Lab Clin Med; 1989 Apr; 113(4):482-92. PubMed ID: 2539420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Con A mitogenesis by serum from procainamide-treated patients and patients with systemic lupus erythematosus.
    Tannen RH; Cunningham-Rundles S
    Immunol Commun; 1982; 11(1):33-45. PubMed ID: 6178682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced lupus.
    J Tenn Med Assoc; 1988 Sep; 81(9):579. PubMed ID: 3263546
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic lupus erythematosus induced by procaine amide.
    Whittingham S; Mackay IR
    Australas Ann Med; 1970 Nov; 19(4):358-61. PubMed ID: 4099201
    [No Abstract]   [Full Text] [Related]  

  • 30. A systemic lupus erythematosus-like syndrome induced by procainamide.
    Zeide MS; Wiesel S; Terry R; Stein D
    Clin Orthop Relat Res; 1978; (134):290-2. PubMed ID: 729256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus.
    Rubin RL; McNally EM; Nusinow SR; Robinson CA; Tan EM
    Clin Immunol Immunopathol; 1985 Jul; 36(1):49-59. PubMed ID: 3874029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
    Ullman S; Wiik A; Kobayasi T; Halberg P
    Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
    [No Abstract]   [Full Text] [Related]  

  • 33. SLE: idiopathic or drug-induced?
    Condemi JJ
    Geriatrics; 1980 Mar; 35(3):81-8. PubMed ID: 6965485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procainamide-induced lupus erythematosus. Clinical and laboratory observations.
    Blomgren SE; Condemi JJ; Vaughan JH
    Am J Med; 1972 Mar; 52(3):338-48. PubMed ID: 4536815
    [No Abstract]   [Full Text] [Related]  

  • 35. Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.
    Anastassiades TP; Miliiken JA
    Can Med Assoc J; 1972 Aug; 107(4):312-5. PubMed ID: 4538330
    [No Abstract]   [Full Text] [Related]  

  • 36. Antinuclear antibody induced by procainamide. A prospective study.
    Blomgren SE; Condemi JJ; Bignall MC; Vaughan JH
    N Engl J Med; 1969 Jul; 281(2):64-6. PubMed ID: 4182059
    [No Abstract]   [Full Text] [Related]  

  • 37. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus.
    Rubin RL; Burlingame RW; Arnott JE; Totoritis MC; McNally EM; Johnson AD
    J Immunol; 1995 Mar; 154(5):2483-93. PubMed ID: 7868914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The reversible procaine amide-induced lupus-erythromatosus syndrome].
    Günther R; Asamer H; Dittrich P
    Dtsch Med Wochenschr; 1969 Nov; 94(45):2338-42. PubMed ID: 4186711
    [No Abstract]   [Full Text] [Related]  

  • 39. The frequency of procainamide-induced systemic lupus erythematosus.
    Hope RR; Bates LA
    Med J Aust; 1972 Aug; 2(6):298-303. PubMed ID: 4117237
    [No Abstract]   [Full Text] [Related]  

  • 40. A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism.
    Lappat EJ; Cawein MJ
    Am J Med; 1968 Dec; 45(6):846-52. PubMed ID: 4177546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.